Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

SBRI Healthcare Launches New Competitions, with £5 Million to Invest this Year

Published: Monday, September 23, 2013
Last Updated: Monday, September 23, 2013
Bookmark and Share
Funding will be awarded in a new round of competitions under the SBRI programme to develop innovative solutions towards better health outcomes.

SBRI Healthcare, an NHS England funded initiative to develop innovative products and services that address unmet health needs, announced a it will distribute £5 million of government investment to support small business this year.

The Small Business Research Initiative (SBRI) healthcare competitions provide seed funding for the development of novel solutions to major healthcare challenges. In this new round of competitions, SBRI Healthcare  will be looking for companies specifically focused on driving towards better health outcomes for patients across seven categories; Cancer, Cardiovascular, COPD, Diabetes, Mental Health/Dementia, Patient Safety and Research Tools.

The Prime Minister’s UK Strategy for Health Innovation and Life Sciences - Innovation, Health and Wealth* (IHW) - set the approach for innovation in the reformed NHS, making a commitment to double investment in the SBRI programme to address healthcare challenges, encourage greater competition in procurement of services and drive growth in the UK Small and Medium size Enterprises (SME) sector.

Investing £17.6 million to date in support of 66 SMEs, the further £5 million in funding is recognition of the value small businesses bring to the NHS to help them deliver new technologies to patients and for these to be adopted widely across the NHS.

Miles Ayling, Director of Innovation, NHS England

“Innovation Health and Wealth set out the agenda to spread best practice across the NHS whilst at the same time supporting economic growth and wealth creation. The Small Business Research Initiative is a way for NHS England to generate a pipeline of new ideas and technologies with predominantly small to medium sized companies. The ideas in this sector are often highly innovative and exciting – bringing a step change to the way the NHS can deliver quality care for patients. In Innovation Health and Wealth the NHS set out to double the investment in SBRI – NHS England has already committed £5m this year and today’s competition launch will support industry with a further £5m investment.”

Sir Mike Rawlins, Chair of the Eastern Academic Health Science Network (EAHSN), who lead the programme on behalf of NHS England commented:

“The NHS is a great market place for new technology companies.  Through the SBRI programme we can find new ways of solving old problems – which benefit patients and support business growth.  In the NHS we have world leading clinical expertise and through programmes such as SBRI Healthcare we can work with business experts to maximise the benefit to the NHS and the economy.”

Peter Ellingworth OBE, Chair of the SBRI Management Board and Chief Executive of the Association of British Healthcare Industries welcomed the new competition:

“The med tech industry is an important success story for the UK economy. Many companies already work closely with the NHS but the SBRI programme supports new partnerships to develop and succeed. Through SBRI the companies can gain funding but also the expert support of the NHS to develop products that are truly reflecting NHS need. I hope many companies take a good look and apply for this programme.”

The competition theme areas have been chosen in partnership with the newly designated Academic Health Science Networks (AHSNs) across England. The programme management is led by the Eastern Academic Health Science Network (EAHSN) on behalf of NHS England and other AHSNs. Health Enterprise East is the management partner and supports the EAHSN to handle the applications, assessments and delivery against contracts.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Three Companies Awarded Funding in Department of Health’s SBRI Healthcare Programme
Funding awarded to develop innovative solutions that address unmet health needs.
Tuesday, July 30, 2013
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Anti-Inflammatory Drugs Could Help Treat Depression
Anti-inflammatory drugs could be used to treat some cases of depression, which further implicates our immune system in mental health disorders.
NIH Contributes to Global Effort to Prevent and Manage Lung Diseases
The large scale trial will measure health benefits of clean cookstoves.
Questioning the Safety of Selenium to Combat Cancer
Research indicates the need for change in practice as selenium supplements cannot be recommended for preventing colorectal cancer.
Scientists at NIH and Emory Achieve Sustained SIV Remission in Monkeys
The finding suggest that the immune systems of these animals are controlling SIV replication in the absence of antiretroviral therapy.
Painting the Way to Tumour Imaging
Tumour paint used in emergency surgery to aid cell identification for surgeons.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
Targeting Estrogen Receptor Improves Survival in Breast Cancer
Trial finds estrogen receptor degrader significantly increases progression-free survival in patients with advanced breast cancer.
Clinical Trial Finds Medicine Program Alters Blood Serum
Meditation, yoga and vegetarian diet linked to decline in plasma metabolites associated with inflammation and cardiovascular disease risk.
Alzheimer’s Linked Protein Can Be Removed From Brain Without Hindering Memory, Learning
Researchers at UTSW have found that the mice can maintain their learning and memory when virtually all ApoE is removed from the brain but kept present in the liver to filter cholesterol.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos